.
.
.
.
Coronavirus

India hits 1 billion COVID-19 vaccine doses

Published: Updated:

India has administered 1 billion doses of COVID-19 vaccine, officials said Thursday, passing a milestone for the South Asian country where the delta variant fueled its first crushing surge earlier this year.

Read the latest updates in our dedicated coronavirus section.

About 75 percent of India’s total eligible adult population have received at least one dose, while nearly 30 percent are fully immunized. The country of nearly 1.4 billion people is the second to exceed a billion cumulative doses after the most populous country China did so in June.

Coronavirus cases have fallen sharply in India since the devastating months at the start of the year when the highly transmissible delta variant, first detected in the country a year ago, was infecting hundreds of thousands daily, sending COVID-19 patients into overwhelmed hospitals and filling cremation grounds.

Officials have bolstered the vaccination campaign in recent months, which experts say have helped control the outbreak since.

Still, there remains a worrying gap between those who have received one shot and those fully immunized. Ramping up the second dose is “an important priority,” V K Paul, the head of the country’s COVID-19 taskforce, said at a briefing last week.

“We would like to see this number go up. Complete coverage is absolutely critical,” he said.

India, an important supplier of vaccines globally, halted exports in April as cases at home surged and only resumed exports earlier this month. The government is now optimistic that the country’s vaccine supply, which has seen a rise, will be enough to cover its international and domestic commitments.

Both of the two main suppliers have ramped up production, with the Serum Institute now producing around 220 million jabs a month and some 30 million from Bharat Biotech, Paul said.

On Wednesday, India confirmed over 14,000 new cases. Its active cases make up less than 1 percent of its total caseload, now more than 34 million, including over 450,000 deaths, according to the health ministry.

Serological surveys done in June and July showed that over 60 percent of the population had antibodies to the virus that causes COVID-19, reducing the likelihood of another massive surge in the coming months, according to some experts.

Even states where infections were swelling a few weeks ago, such as Kerala along the tropical Malabar coast, have seen a sustained decline.

“There is a sense of comfort that India has suffered the worst of the delta variant, but this must be accompanied with a feeling of caution,” said Reddy.

“Even if cases go up, we are unlikely to see the scale of the surge earlier — if that does happen, it would be fairly unexpected,” he added.

In recent months, life in India has swung back to normal. Markets are buzzing with activity, tourists can enter the country after a 19-month hiatus and the country is gearing up to celebrate Diwali, the Hindu festival of lights.

But there are fears this could be a lull before the storm. Even though India may have borne the brunt of the delta variant already, things could escalate quickly if a new variant emerges — either from within the country or outside.

“If the virus becomes different or mutates, it changes the dynamics. This could change everything,” said Paul.

Read more:

India’s COVID-19 vaccination campaign slows as dose gap trumps output jump: Data

COVID-19 reinfection likely for unvaccinated: Study

Britain secures COVID-19 antivirals from Merck and Pfizer

Top Content Trending